Merck (MRK) Net Cash Flow Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
NCF Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
-568.73% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-85.99% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
1,265.92% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-95.55% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
191.97% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
103.60% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
42.41% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-227.06% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-95.55% |
| Dec 31, 2025 |
-258.23% |
| Sep 30, 2025 |
236.88% |
| Jun 30, 2025 |
-117.86% |
| Mar 31, 2025 |
-331.09% |
| Dec 31, 2024 |
48.46% |
| Sep 30, 2024 |
-2.99% |
| Jun 30, 2024 |
245.29% |
| Mar 31, 2024 |
64.22% |
| Dec 31, 2023 |
-272.52% |
| Sep 30, 2023 |
60.68% |
| Jun 30, 2023 |
-374.93% |
| Mar 31, 2023 |
-712.35% |
| Dec 31, 2022 |
164.57% |
| Sep 30, 2022 |
32.56% |
| Jun 30, 2022 |
-11.00% |
| Mar 31, 2022 |
132.51% |
| Dec 31, 2021 |
-2,155.29% |
| Sep 30, 2021 |
133.57% |
| Jun 30, 2021 |
-28.42% |
| Mar 31, 2021 |
35.96% |
| Dec 31, 2020 |
103.49% |
| Sep 30, 2020 |
-444.27% |
| Jun 30, 2020 |
259.51% |
| Mar 31, 2020 |
-2,778.89% |
| Dec 31, 2019 |
-1,294.12% |
| Sep 30, 2019 |
-50.35% |
| Jun 30, 2019 |
-230.97% |
| Mar 31, 2019 |
105.10% |
| Dec 31, 2018 |
111.18% |
| Sep 30, 2018 |
6,977.78% |
| Jun 30, 2018 |
127.01% |
| Mar 31, 2018 |
-135.71% |
| Dec 31, 2017 |
-100.88% |
| Sep 30, 2017 |
-97.11% |
| Jun 30, 2017 |
-23.41% |
| Mar 31, 2017 |
371.37% |
| Dec 31, 2016 |
-174.24% |
| Sep 30, 2016 |
75.25% |
| Jun 30, 2016 |
-770.40% |
| Mar 31, 2016 |
25.66% |
| Dec 31, 2015 |
133.94% |
| Sep 30, 2015 |
-62.68% |
| Jun 30, 2015 |
93.86% |
| Mar 31, 2015 |
379.31% |
| Dec 31, 2014 |
-328.18% |
| Sep 30, 2014 |
289.93% |
| Jun 30, 2014 |
-380.86% |
| Mar 31, 2014 |
174.68% |
| Dec 31, 2013 |
141.48% |
| Sep 30, 2013 |
-278.47% |
| Jun 30, 2013 |
6.73% |
| Mar 31, 2013 |
-120.10% |
| Dec 31, 2012 |
-458.21% |
| Sep 30, 2012 |
-72.85% |
| Jun 30, 2012 |
272.21% |
| Mar 31, 2012 |
77.22% |
| Dec 31, 2011 |
-155.13% |
| Sep 30, 2011 |
78.29% |
| Jun 30, 2011 |
67.79% |
| Mar 31, 2011 |
177.86% |
| Dec 31, 2010 |
109.92% |
| Sep 30, 2010 |
-87.55% |
| Jun 30, 2010 |
-94.86% |
| Mar 31, 2010 |
-149.10% |
